- Home
- /
- Treatment
- /
- Page 86
Treatments
The following database contains products that have been granted orphan status, or have been market approval in the EU or the USA.
You can filter the content by clicking on the titles: Product, Indication, Sponsor and Date. Clicking once, will filter the column alphabetically from A – Z and a second click on the same title will filter from Z – A.
Become a Partner.
Country | Product | Indication | Sponsor | Date |
---|---|---|---|---|
1-(2-C-cyano-2-deoxy-B-D-arabino-pentafuranosyl)-N4-palmitoylcytosine | Acute myeloid leukemia | Cyclacel Limited;1 James Linday Place, Dundee DD1 5JJ; | June 24, 2010 | |
Angiotensin 1-7 | To accelerate engraftment of hematopoietic cells (treatment of neutropenia, thrombocytopenia, lymphoma, and aneima)in hematopoietic stem cell transplants | Tarix Pharmaceuticals, Ltd.;12 Bow Street;Cambridge, Massachusetts, 02138 | June 17, 2010 | |
Dasiprotimut-T | Mantle cell lymphoma | Biovest International, Inc.;324 S. Hyde Park Ave.;Tampa, Florida, 33606 | June 17, 2010 | |
N-{2-Chloro-4-[(6,7-dimethoxy-4-quinolyl)oxy]phenyl}-N’-(5-methyl-3-isoxazolyl) urea hydrochloride monohydrate | Renal cancer | EUSA Pharma (UK) Limited | June 9, 2010 | |
Bosentan | Systemic scleroderma | Actelion Ltd.;Gewerbestrasse 16, CH-4123; | June 7, 2010 | |
Anti-TCR murine monoclonal antibody (MAb, type IgM) | Patients 16 years of age and younger with immune-mediated T1DM and preserved pancreatic beta cell function | Tolera Therapeutics, Inc.;350 E. Michigan Avenue;Kalamazoo, Michigan, 49001 | June 7, 2010 | |
Dendritic cells pulsed with synthetic peptides derived from antigens MAGE1, HER-2, AIM-2,TRP-2, gp100 and interleukin-13 receptor alpha | Glioblastoma | ImmunoCellular Therapeutics Ltd.;21900 Burbank Blvd;Woodland Hills, California, 91367 | June 7, 2010 | |
Anti-thymocyte globulin [rabbit] | Prophylaxis of acute organ rejection in patients receiving renal transplants | Genzyme Corporation;500 Kendall Street;Cambridge, Massachusetts, 02142 | May 25, 2010 | |
N-(6-2-aminophenylamino)-6-oxohexyl)-4-methylbenzamide | Friedreich Ataxia | Repligen Corporation;Building 1, Suite 100;Waltham, Massachusetts, 02453 | May 17, 2010 | |
BF2.649 (Pitolisant) | Narcolepsy | Bioprojet Pharma;9, rue Rameau;Paris | May 17, 2010 | |
Budesonide | To slow the progression of immunoglobulin A nephropathy & delay kidney failure in patients affected by the disease | Calliditas Therapeutics AB;Wallingata 26b;Stockholm | May 17, 2010 | |
Bone marrow-derived mononuclear cells | Buerger’s disease | t2cure GmbH;Kennedyallee 93, 60596 Frankfurt am Main; | May 17, 2010 | |
Hydroxy-Propyl-Beta-Cyclodextrin | Niemann Pick Disease, Type C | Sphingo Biotech, LLC;14120 NW 126th Terrace;Alachua, Florida, 32615 | May 17, 2010 | |
Lentiviral vector containing the human MY07A gene | Retinitis pigmentosa | Sanofi US Services, Inc.;55 Corporate Drive, Mail Stop 55D-220B;Bridgewater, New Jersey, 08807 | May 17, 2010 | |
Glyeraldehyde-3-phosphate dehydrogenase | Pediatric multiple sclerosis | BPT Pharmaceuticals, Inc.;743 North Sweetzer Avenue #103;Los Angeles, California, 90069 | April 30, 2010 | |
Replication-incompetent GM-CSF-expressing gene-modified allogeneic chronic myeloid leukemia cancer cell lines | Chronic myeloid leukemia | Aduro BioTech, Inc.;740 Heinz Avenue;Berkeley, California, 94710 | April 30, 2010 | |
Auranofin | Amebiasis | Ctr for Discovery & Innovation in Parasitic Diseas;U. of CA, San Francisco, QB3, Byers Hall 508B;San Francisco, California, 94158 | April 30, 2010 | |
AEZS-108 (LHRH-agonist linked to doxorubicin) | Ovarian cancer | Aeterna Zentaris;100 Marketplace, Suite 203, 25 Mountainview Blvd;Basking Ridge, New Jersey, 07920 | April 30, 2010 | |
Midostaurin | Mastocytosis | Novartis Oncology;One Health Plaza;East Hanover, New Jersey, 07936 | April 30, 2010 | |
Ex-vivo cultered adult human mesenchymal stem cells | Type 1 diabetes patients with residual beta cell function | Mesoblast, Inc.;505 Fifth Avenue, Third Floor;New York, New York, 10017 | April 30, 2010 | |
Midostaurin | Mastocytosis | Novartis Oncology;One Health Plaza;East Hanover, New Jersey, 07936 | April 30, 2010 | |
Cinacalcet | Hypercalcemia in patients with primary hyperparathyroidism for whom parathyroidectomy would be indicated on the basis of serum calcium levels, but who are unable to undergo surgery | Amgen, Inc.;One Amgen Center Drive, Bldg 17, 1A-4-4, Mail Stop 17-1-B;Thousand Oaks, California, 91320 | April 30, 2010 | |
Cintredekin Besudotox | Idiopathic pulmonary fibrosis | Insys Development Company, Inc.;1333 South Sprectum Blvd, Suite 100;Chandler, Arizona, 85286 | April 30, 2010 | |
3,4 diaminopyridine and choline bitartrate | Lambert-Eaton Myasthenic Syndrome | MS Therapeutics Limited;Beechy House, Berkshire RG45 7AW; | April 30, 2010 | |
Human monoclonal antibody targeting CC-chemokine ligand 2 (CNTO 888) | Ovarian cancer | Ortho Biotech;200 Great Valley Parkway;Malvern, Pennsylvania, 19355 | April 30, 2010 |